NexStar Pharm(NXTR) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
NexStar Pharm(NXTR)

An SI Board Since December 1996

Posts	SubjectMarks	Bans	Symbol
328	5	0	NXTR

Emcee: Miljenko Zuanic	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
53	Growth Factor Stimulates AIDS-Related Kaposi's Sarcoma WESTPORT, Feb 04 (	Miljenko Zuanic	-	2/4/1997
52	Oppenhiemer (sp) today upgraded NXTR to a buy from out perform.	Bill Tomko	-	2/4/1997
51	Prior to investing I spoke with someone who I believe to be very informed about	Bill Tomko	-	2/1/1997
50	Composition of AmBisome? LIPO's Abelcet (chemically it is complex) is compo	Miljenko Zuanic	-	1/31/1997
49	I'm in!!! I used a trading mentality vs investor. I bought stock and sim. s	Bill Tomko	-	1/31/1997
48	I'm not sure I understand your inquiry. I do not have any of the specific t	Bill Tomko	-	1/31/1997
47	TO ALL!! Need urgently!!!! AmBisome-Liposomal Amphotericin B-Matter of conten	Miljenko Zuanic	-	1/30/1997
46	Bill, I was TCLN shareholder until last Friday. Glad that I break even after o	Miljenko Zuanic	-	1/30/1997
45	Did you see the Jan. 24'th issue of Science article on vascular targeting a	Bill Tomko	-	1/29/1997
44	I'm locked and loaded. ready on the line. HOPING for some weakness.	Bill Tomko	-	1/29/1997
43	Bill, I bought today few hundred at 16 1/8! Miljenko	Miljenko Zuanic	-	1/28/1997
42	Bill, Thanks for info. miljenko	Miljenko Zuanic	-	1/28/1997
41	I forgot to point out that there is a article in the Jan. 11, issue of Lancet r	Bill Tomko	-	1/28/1997
40	Miljenko, of course your reading of the two patents would be very helpful. I t	WWS	-	1/28/1997
39	Bill, even in last Bill Tomko reply I sense FEAR regarding the LIPO patent infr	Miljenko Zuanic	-	1/27/1997
38	Bill, very good questions. NXTR has LOTS of potential (yet unrealized). But t	WWS	-	1/27/1997
37	I basically understand the tech. opportunities to be as you highlighted them.I	Bill Tomko	-	1/27/1997
36	I'm still looking at it. I think I have a line on a meeting with one of the	Bill Tomko	-	1/27/1997
35	Bill, Forgot to ask you one thing regarding CNSI. Cerestat is noncompetitive N	Miljenko Zuanic	-	1/26/1997
34	Investment opportunity! General: Liposome encapsulated technology -drug delive	Miljenko Zuanic	-	1/26/1997
33	Thanks for reply. Since I do not have scientific expertise I tend to rely on ot	icanpickem	-	1/26/1997
32	As you may be aware from my past postings, I have only recently begun to evalua	Bill Tomko	-	1/26/1997
31	At the present I can't be specific about possible application. First, my kn	Miljenko Zuanic	-	1/25/1997
30	Interesting information as company has not, to my knowlege, indicated any inte	icanpickem	-	1/25/1997
29	Bill, It is very simple. For recent patent on any subjects or company url is: p	Miljenko Zuanic	-	1/24/1997

Go to reply# or date (mm/dd/yy):